Michigan program
Coverage rules for chemotherapy drugs
Michigan’s insurance regulator lists chemotherapy drugs and the reasonable cost of giving them as required coverage.
What it is
Michigan’s insurance regulator lists chemotherapy drugs and the reasonable cost of giving them as required coverage.
A chemotherapy denial can involve both the drug and its administration. The state regulator’s coverage list gives a point to raise in an appeal. The plan’s legal type still needs checking.
Eligibility rules
- Michigan-regulated plans must cover chemotherapy drugs and the cost of giving them, including some off-label uses when the evidence supports it. A private employer that pays its own claims is not bound; ask HR which kind of plan you have.
What you get
- A required-coverage provision to discuss when a chemotherapy drug or its administration is refused.
What the help covers
- The DIFS required-coverage page names a drug used in antineoplastic therapy and the reasonable cost of administering it.
If you decide to apply
- Ask the social worker to check the denial and plan type with the insurer or DIFS.
- Bring the drug name, denial letter and oncologist’s explanation if you decide to pursue an appeal.
The insurer, then the state external review · Official page ↗
If you decide to apply
- The insurer’s appeal process is the starting point. DIFS external review has its own plan and deadline requirements.
- A plan must answer a treatment request within seven days, or 72 hours when urgent. (a prior-authorization rule folded into a coverage card; Michigan has no prior_auth_rights card)
Good to know
Michigan also has a newer law on what chemo pills can cost on an insured plan; if a pill charge looks high, ask the plan which option it follows.
Other details
- For plans issued or renewed from 2026, chemotherapy pills cannot cost you more than infused chemotherapy, or the plan can instead cap your share at about $255 a month. Ask the plan which it uses. (this is a separate oral-chemo-parity card folded into the coverage card; give it its own card as every other state does)
- DIFS and the actual plan can confirm any additional fertility-preservation coverage or copay-accumulator rule. The oral-drug cost-sharing law does not settle those separate questions.
Official sources
“Could the state chemotherapy coverage rule help with a refusal? What would it change or leave unresolved, and could you help with an appeal if the rule applies?”
Why I’m asking: I want to distinguish a coverage right from a promise about what the medicine costs us.
More background and detailed requirements
Additional program information and published rules
Who does what
The three parts, side by side. The agency decides; nobody on this page does.
You
Put the regulator’s wording in the written appeal.
Your social worker
The plan answers in writing.
The care team
The oncologist confirms the drug is part of the treatment.
- Who decides
- The insurer, then an independent reviewer.
- Ask your social worker
- “The plan is refusing a chemotherapy drug. Can we quote the state regulator’s required-coverage list in the appeal?”
How to apply
First step: Quote the regulator’s required-coverage page in a written appeal to the plan.
- Ask the social worker and care team which coverage or cost-sharing rule fits the denial and plan.
- If you choose an appeal, the team can help supply the drug records and confirm the correct review route and deadline.
Official application / program page ↗
Where it starts: Quote the regulator’s required-coverage page in the appeal.
What to gather
- The refusal letter
- The drug name and the oncologist’s note
How long: Michigan’s prior-authorization law generally uses seven calendar days for a nonurgent decision and 72 hours for an urgent one. Missing-information and missed-deadline rules have conditions. DIFS and the care team can check the particular request. The law expressly includes state and local self-funded employee plans and excludes Medicaid; that scope does not decide every other mandate.
What a yes looks like
The plan reverses and pays for the drug and the infusion.
What a no looks like, and the next move
The social worker can check DIFS review eligibility and the current form’s receipt-based filing deadline.
Watch out
- For covered policies issued or renewed after December 31, 2025, the oral-antineoplastic law allows equal-or-less-restrictive oral financial requirements or a capped copay-and-coinsurance alternative. The alternative is $254.75 per 30-day supply in 2026; it is not a universal deductible-inclusive maximum.
- A private self-funded employer plan is not bound simply because an insurer administers it. Public self-funded plans need a statute-specific check.
The numbers and the rules
The arcane layer, kept on purpose. Checked September 11, 2026.
What it is worth
The state regulator lists chemotherapy drugs and the reasonable cost of giving them as required coverage.
Legal protection: MCL 500.3406e requires covered Michigan health insurance policies to include an antineoplastic drug and reasonable administration costs; its off-label cancer-use protection has specific medical-evidence and consent conditions. Michigan-regulated fully insured employer, school and Marketplace policies may fall within that rule. A private self-funded employer plan is not bound merely because the same insurer administers it, and a self-funded public plan needs a separate legal check. DIFS and the plan document can establish the rule that applies to this policy. · Michigan now has a separate oral-antineoplastic cost-sharing law for covered policies delivered, issued or renewed after December 31, 2025. When a policy covers both oral and injected or infused antineoplastic treatment, it must either make the oral financial requirements no more restrictive or use the law’s capped copay-and-coinsurance option. That option is $254.75 for a 30-day supply in calendar 2026, under DIFS Bulletin 2026-02-INS; it is not a universal cap on every out-of-pocket charge. Prior authorization and other lawful treatment limits can still apply. Your social worker can help DIFS check the policy, its renewal date and which option it uses.
What it costs the family: None to quote.
The eligibility facts, as published
- Plans
- MCL 500.3406e requires covered Michigan health insurance policies to include an antineoplastic drug and reasonable administration costs; its off-label cancer-use protection has specific medical-evidence and consent conditions. Michigan-regulated fully insured employer, school and Marketplace policies may fall within that rule. A private self-funded employer plan is not bound merely because the same insurer administers it, and a self-funded public plan needs a separate legal check. DIFS and the plan document can establish the rule that applies to this policy.
The trap: For covered policies issued or renewed after December 31, 2025, the oral-antineoplastic law allows equal-or-less-restrictive oral financial requirements or a capped copay-and-coinsurance alternative. The alternative is $254.75 per 30-day supply in 2026; it is not a universal deductible-inclusive maximum.
Where I read this
- DIFS: Required Health Insurance Coverage — Michigan DIFS, read September 10, 2026